Stocks and Investing Stocks and Investing
Tue, February 21, 2017
Mon, February 20, 2017

DGI, LOV, IDRA, MYY, XPL, AVAV Are Seasonally Ripe To Go Down In the Next Five Weeks


Published on 2017-02-20 01:45:47 - WOPRAI
  Print publication without navigation


February 20, 2017 / M2 PRESSWIRE / BUYINS.NET / www.buyins.net is monitoring the Seasonality of DigitalGlobe Inc. (NYSE:DGI), Spark Networks, Inc. (NYSE:LOV), Idera Pharmaceuticals Inc. (NASDAQ:IDRA), ProShares Short MidCap400 (NYSE:MYY), Solitario Exploration & Royalty Corp (NYSE:XPL), AeroVironment, Inc. (NASDAQ:AVAV) and each have a high seasonal probability to go Down in the next weeks. By identifying stocks that are poised to go up or down based on seasonal tendencies, traders can increase their odds of making money. buyins.net is able to analyze over 20 years of data in less than 1 second for any stock in the market and determine if the stock has a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias. The technology used to generate these predictions is available for a low monthly fee at:

The following stocks are expected to go Down:

  Symbol  Company                          Expected Return  Odds                 By The Following Date
  DGI     DigitalGlobe Inc.                -2.78%           85.71% (6 of 7)      Wednesday, February 22nd 2017
  LOV     Spark Networks, Inc.             -2.53%           88.89% (8 of 9)      Tuesday, February 28th 2017
  IDRA    Idera Pharmaceuticals Inc.       -9.59%           80.95% (17 of 21)    Wednesday, March 1st 2017
  MYY     ProShares Short MidCap400        -5.07%           90.00% (9 of 10)     Friday, March 31st 2017
  XPL     Solitario Exploration & Royalty Corp  -8.89%           90.00% (9 of 10)     Friday, March 17th 2017
  AVAV    AeroVironment, Inc.              -3.06%           100.00% (10 of 10)   Friday, February 24th 2017
DigitalGlobe Inc. (NYSE:DGI) - DigitalGlobe, Inc. provides earth-imagery products and services sourced from own satellite constellation and third-party providers in the United States and internationally. The company offers customer-ready imagery products that are designed to enable customers to understand and analyze specific geographies of interest; analytic solutions to derive insights from imagery; on- and off-line distribution options that are designed to enable customers to access and integrate its imagery into their business operations and applications; and Direct Access Program that enables to directly task and receive imagery from its satellites within local and regional geographic boundaries of interest, as well as platform products, such as Geospatial Big Data and Spatial on Demand platforms for assembling content and large-scale analytical tools in a single environment. Its products and services support users in various fields, including defense and intelligence, civil agencies, mapping and analysis, environmental monitoring, oil and gas exploration, infrastructure management, Internet portals, and navigation technology. The company s principal customers include U.S. and foreign governments, LBS providers, and those in energy and other industry verticals. It sells its products and services through a combination of direct and indirect channels consisting of a network of resellers, strategic partners, direct enterprise sales, and Web services. DigitalGlobe, Inc. has a strategic alliance with exactEarth Ltd. The company was formerly known as EarthWatch, Incorporated and changed its name to DigitalGlobe, Inc. in August 2002. DigitalGlobe, Inc. was incorporated in 1993 and is headquartered in Westminster, Colorado..

Spark Networks, Inc. (NYSE:LOV) - Spark Networks, Inc. provides online personals services in the United States and internationally. It operates in four segments: Jewish Networks, Christian Networks, Other Networks, and Offline and Other Businesses. The company creates iconic, niche-focused brands and communities that help individuals form life-long relationships with others that share their interests and values. Its primary properties include JDate.com and ChristianMingle.com, which are communities geared towards singles of the Jewish and Christian faiths. The company, through its Websites and mobile applications, helps members search for and communicate with other like-minded individuals. Its online singles properties provide users with services, such as searching for compatible individuals with whom to potentially form long-term relationships; validating compatibility through profiles, viewing photographs, and understanding likes and characteristics; and communicating through a communications platform designed to foster relationships. The company s online and web services offer various features that include posting of a personal profile and photos, onsite email, hotlists and favorites, message boards, mobile chat, chat rooms, instant messaging services, ice breakers, and Click ; and are available in English, Hebrew, and French languages. It also operates four different media properties primarily focused on serving the Christian community. As of December 31, 2014, it had 203,557 average paying subscribers. The company was incorporated in 2007 and is headquartered in Los Angeles, California..

Idera Pharmaceuticals Inc. (NASDAQ:IDRA) - Idera Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for oncology and rare diseases in the United States. It uses two proprietary drug discovery technology platforms to design and develop drug candidates, including toll-like receptor targeting technology and third-generation antisense (3GA) technology. The company s lead drug candidate is IMO-8400, which is in Phase I/II clinical trials for the treatment of Waldenstr m s Macroglobulinemia and diffuse large B-cell lymphoma, as well as in Phase II clinical trial for the treatment of dermatomyositis. Its drug candidates also comprise IMO-9200, a drug candidate in Phase I clinical trial for use in selected autoimmune disease indications; and IMO-2055/IMO-2125 that are in Phase I/II clinical trials for applications as immune therapies for the treatment of cancer. In addition, the company is developing drug candidates to turn off the messenger RNA associated with disease causing genes. It has license and research collaboration agreement with Merck & Co. to research, develop, and commercialize vaccine products containing TLR7, TLR8, and TLR9 agonists in the fields of cancer, infectious diseases, and Alzheimer s disease; an agreement with Abbott Molecular Inc. for the development of an in vitro companion diagnostic test; a collaboration and license agreement with GSK to research, develop, and commercialize selected molecules from its 3GA technology for the treatment of selected targets in renal disease. Idera Pharmaceuticals, Inc. was founded in 1989 and is based in Cambridge, Massachusetts..

ProShares Short MidCap400 (NYSE:MYY) - SHORT MIDCAP400.

Solitario Exploration & Royalty Corp (NYSE:XPL) - Solitario Exploration & Royalty Corp. engages in the acquisition, exploration, and development for precious and base metal properties in Peru, Brazil, and Mexico. The company primarily explores for gold, silver, platinum, palladium, copper, lead, and zinc deposits. It primarily holds interests in the Bongar project comprising 16 concessions that covers an area of 12,600 hectares located in the Department of Amazonas, northern Peru; Chambara zinc property located in northern Peru; Newmont Alliance and the La Promesa project located in Peru; Yanacocha royalty property that consists of 69 concessions covering an area of approximately 61,000 hectares located in northern Peru; and Norcan and Aconchi copper properties located in Mexico. The company was formerly known as Solitario Resources Corporation and changed its name to Solitario Exploration & Royalty Corp. in June 2008. Solitario Exploration & Royalty Corp. was founded in 1984 and is based in Wheat Ridge, Colorado..

AeroVironment, Inc. (NASDAQ:AVAV) - AeroVironment Inc. designs, develops, produces, supports, and operates unmanned aircraft systems (UAS) and efficient energy systems (EES) in the United States and internationally. The company offers small UAS products to deliver intelligence, surveillance, and reconnaissance; and communications, such as real-time tactical reconnaissance, tracking, combat assessment, and geographic data to the small tactical unit or individual operator. Its small UAS wirelessly transmit critical live video and other information to a hand-held ground control unit enabling the operator to view and capture images; ground control systems allow the operator to control the aircrafts; and tactical missile systems designed to be reusable for flights under normal operating circumstances and can be recovered through an autonomous landing feature that enables a controlled descent to a designated location. The company also provides spare equipment, alternative payload modules, batteries, and chargers; repair, refurbishment and replacement, training, and customer support services to small UAS; turnkey mission services; and contract engineering services. In addition, it offers electric vehicle charging systems, services, and related solutions for plug-in passenger and fleet vehicles; PosiCharge industrial electric vehicle charging systems for electric material handling vehicles and airport ground support equipment; and power cycling and test systems for developers and manufacturers of electric vehicles, as well as battery packs, electric motors, and fuel cells. The company sells EES products directly through sales force; and through retailers, resellers, industrial battery and lift-truck dealers, and distributors and representatives. It serves the U.S. Department of Defense, including the U.S. Army, Marine Corps, Special Operations Command, and Air Force, as well as commercial, consumer, and government customers. AeroVironment Inc. was founded in 1971 and is headquartered in Monrovia, California..

About BUYINS.NET

BUYINS.NET, http://www.buyins.net, monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market-maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:

REGULATORY & COMPLIANCE NEWS Friction Factor - Market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements" Naked Shorts (RegSho) - Tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO

INVESTMENTS & TRADING Earnings - Predicts probability, price move and length of move before and after all US stock earnings reports Seasonality - Predicts probability, price move and length of move based on exact time of year for all US stocks Group Correlation - Tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups SqueezeTrigger - Massive database that tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock. Valuation - Tracks all known valuation models and applies them. GATS - Tracks and quantifies known trading strategies by backtesting, optimizing and running genetic algorithms and neural networks to ascertain best trading strategies. PatternScan - Automates tracking of every technical pattern and predicts next move in stocks. Insider - Tracks insiders trading records and determines trading performance. Trades by higher-level insiders are generally more predictive than trades by lower level insiders Events - Tracks patterns directly correlated to specific events.

SqueezeTrigger is a registered trademark, Reg. No. 3,120,641

DISCLAIMER:

BUYINS.NET is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. [symbol] has not approved the statements made in this release. Please read our report and visit our web site, http://www.buyins.net, for complete risks and disclosures.

Contact: BUYINS.NET Thomas Ronk 800-715-9999 tom@buyins.net http://www.buyins.net


Contributing Sources